4//SEC Filing
Obermayr Franz 4
Accession 0001104659-21-011844
CIK 0001372514other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:50 PM ET
Size
5.7 KB
Accession
0001104659-21-011844
Insider Transaction Report
Form 4
Obermayr Franz
Acting CEO
Transactions
- Award
Stock Option (right to buy)
2021-02-01+30,000→ 30,000 totalExercise: $6.46Exp: 2031-02-01→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001843571
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 9:50 PM ET
- Size
- 5.7 KB